SJS Investment Consulting’s ImmunityBio IBRX Stock Holding History

SJS Investment Consulting’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$77	Sell	10 -54	-84%	-$370	﹤0.01%	2180
2025 Q4	$127	Buy	+64	New	+$145	﹤0.01%	1914
2025 Q2	–	Sell	-9	Closed	-$28	–	1598
2025 Q1	$28	Sell	9 -41	-82%	-$124	﹤0.01%	1583
2024 Q4	$128	Buy	50 +32	+178%	+$133	﹤0.01%	1503
2024 Q3	$67	Sell	18 -40	-69%	-$185	﹤0.01%	1599
2024 Q2	$367	Buy	58 +47	+427%	+$310	﹤0.01%	1387
2024 Q1	$60	Buy	+11	New	+$50	﹤0.01%	1601
2023 Q2	–	Sell	-3	Closed	-$6	–	1611
2023 Q1	$6	Sell	3 -1	-25%	-$3	﹤0.01%	1576
2022 Q4	$20	Buy	+4	New	+$22	﹤0.01%	1580
2022 Q1	$0	Buy	+1	New	+$6	﹤0.01%	1000

Other funds holding IBRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return